West Japan Oncology Group
Japan's second national cooperative group, born in thoracic oncology; its WJTOG3405 trial helped establish EGFR inhibitors as first-line lung cancer therapy.
Founded in 2000 as the West Japan Thoracic Oncology Group and renamed WJOG in 2008 as it expanded into gastrointestinal, breast and other cancers. WJTOG3405 (gefitinib versus cisplatin-docetaxel in EGFR-mutant NSCLC) was one of the two Japanese phase 3 trials that made EGFR testing and first-line targeted therapy the standard worldwide. WJOG runs investigator-initiated trials of targeted agents, immunotherapy and chemotherapy across Japan's university and cancer centre hospitals and collaborates with JCOG and with Asian and Western groups. Its committees cover thoracic, gastrointestinal, breast, gynaecologic and genitourinary cancers.
- Thoracic oncology (WJTOG3405)
- Gastrointestinal oncology
- Breast oncology
- Investigator-initiated trials of targeted therapy and immunotherapy
Pages like this
not linked directly; found by shared links- PersonYuichiro Ohe
Shares Japanese Society of Medical Oncology, National Cancer Center Hospital, Osimertinib, Small-cell lung cancer.
- PersonHaruhiko Fukuda
Shares Japan Clinical Oncology Group (JCOG), National Cancer Center Hospital, Gastric & gastro-oesophageal junction cancer, Non-small-cell lung cancer.
- InstitutionHunan Cancer Hospital
Shares Small-molecule kinase inhibitors, Gastric & gastro-oesophageal junction cancer, Immune checkpoint inhibitors, Colorectal cancer.
- CollectionJapanese oncology guidelines (JSMO, JSCO and organ societies)
Shares Japanese Society of Medical Oncology, Japan Clinical Oncology Group (JCOG), National Cancer Center Hospital, Gastric & gastro-oesophageal junction cancer.
- InstitutionKyushu University Hospital
Shares Japan Clinical Oncology Group (JCOG), National Cancer Center Hospital, Gastric & gastro-oesophageal junction cancer, Non-small-cell lung cancer.
- InstitutionAichi Cancer Center
Shares Japan Clinical Oncology Group (JCOG), Gastric & gastro-oesophageal junction cancer, Colorectal cancer, Non-small-cell lung cancer.
- InstitutionOsaka International Cancer Institute
Shares Japan Clinical Oncology Group (JCOG), Gastric & gastro-oesophageal junction cancer, Colorectal cancer, Non-small-cell lung cancer.
- InstitutionShizuoka Cancer Center
Shares Japan Clinical Oncology Group (JCOG), Gastric & gastro-oesophageal junction cancer, Colorectal cancer, Non-small-cell lung cancer.